University Hospitals in Cleveland receives grants to support its Workforce Development programs that helps residents from Cleveland's inner city gain employment at the health system's main campus, University Hospitals Cleveland Medical Center.
Black infants born prematurely are at higher risk for recurrent wheezing. This condition can cause the baby discomfort and is a risk factor for developing asthma later in life. In a study published in the Journal of the American Medical Association, a UH Rainbow Babies & Children’s Hospital physician researcher found black preterm infants experienced a significant decrease in recurrent wheezing with sustained supplementation of vitamin D.
Announcement of Case Western Reserve University and PAVmed signing a license agreement to commercialize EsoCheck technology which combines a non-invasive, cell-sampling device with highly accurate DNA biomarkers to detect Barrett's Esophagus. University Hospitals in Cleveland will implement use of the technology.
Announcing that national and international nominations are sought for 2019 Harrington Prize for Innovation in Medicine, honoring a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application.
Psychologist Kimberly Burkhart of University Hospitals Rainbow Babies and Children's Hospital reviews signs of depression in children.
University Hospitals Harrington Heart & Vascular Institute officially opened the APOLLO trial today implanting the Intrepid transcatheter mitral valve replacement system on the first patient involved in the study. Drs. Alan Markowitz and Guilherme F. Attizzani performed the first procedure in the state of Ohio.
Announcement of the fifth annual Harrington Prize for Innovation in Medicine being awarded to Helen H. Hobbs, MD, investigator of the Howard Hughes Medical Institute and Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center.
Announcement of funding opportunity for physician-scientists to advance their discoveries into medicines.
Andrew Pieper, MD, PhD, one of the nation’s leading physician-scientists in the field of neuropsychiatric disorders, has joined the Harrington Discovery Institute – part of The Harrington Project for Discovery & Development – at University Hospitals in Cleveland.
Tip sheet about potential injuries that could be caused by using cotton swabs to clean ears and safer options.
Article about research underway for uterine fibroids at University Hospitals Cleveland Medical Center.
University Hospitals in Cleveland has been recognized as one of the most ethical companies for 2018 by the Ethisphere Institute.
Marlene R. Miller, MD, MSc, has been appointed Pediatrician-in-Chief for University Hospitals and chair of the Department of Pediatrics at University Hospitals Rainbow Babies & Children’s Hospital (UH Rainbow). Dr. Miller will also be nominated for appointment by President Barbara R. Snyder as chair of Case Western Reserve University School of Medicine's Department of Pediatrics at University Hospitals Cleveland Medical Center. She comes to UH from the Johns Hopkins Children’s Center in Baltimore, where she served as vice chair of quality and safety since 2003, and as chief quality officer, pediatrics, for the health system since 2014.
Announcement of deputy director for research at University Hospitals Seidman Cancer Center in Cleveland.
Announcement of new chief marketing officer for the University Hospitals system in Northeast Ohio.
University Hospitals (UH) system in Cleveland names the first president for UH Ventures to build business endeavors, seek opportunities, and expand existing programs
Announcement of the 2018 Harrington Scholar-Innovator Award recipients by the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio.
Announcement of $6.5 million gift from Cleveland philanthropists Sara and Chris Connor for integrative health network at University Hospitals in Northeast Ohio. The will enable UH to recruit a core team of physician leaders to treat patients, educate physicians throughout UH and beyond about how to effectively incorporate integrative therapies into their patient care plans, and conduct research.
A neurosurgery resident has received funding to use a neurosurgical 3-D virtual reality program to enhance patient-doctor communication.
The final results of the DAWN study, published in The New England Journal of Medicine, show that select patients with stroke caused by a blood clot can be effectively treated with a procedure to remove the clot mechanically – and that this can be done up to 24 hours after the onset of symptoms.
Dr. Anthony Furlan of University Hospitals in Cleveland was given the Neurologist Pioneering Award from the Society of Vascular and Interventional Neurology (SVIN).
The Leapfrog Group released its news hospital safety grades, and five hospitals with the University Hospitals system in Northeast Ohio earned the grade of "A."{
Release about administrator from Medicare and Medicaid Services visiting University Hospitals Cleveland Medical Center.
University Hospitals recently announced that accomplished surgeon Nicole Maronian, MD, has been promoted to lead University Hospitals Ear, Nose & Throat (ENT) Institute, effective immediately.
Study in journal Nature Medicine demonstrates, for the first time, that glioblastoma (GBM) is driven by two distinct subsets of cancer stem cells. Moreover, each subtype of glioma stem cells is driven by distinct transcriptional programs for growth and treatment resistance, and these different cell populations correspond to well-known morphological differences within the GBM itself. More importantly, the researchers found that while chemotherapeutic agents targeting each subtype achieve modest efficacy alone, they are synergistic when combined as demonstrated in a mouse model.
University Hospitals clinicians are the first in Northeast Ohio to have access to the Community Health Record through CliniSync’s single sign on technology, making access to critical information from other health care facilities more efficient and timely than ever before.
University Hospitals Cleveland Medical Center once again has been recognized as one of the nation's best hospitals for 2017–18 by U.S. News & World Report. UH Cleveland Medical Center was named among the country’s Top 50 in eight methodology-ranked specialties. The annual U.S. News Best Hospitals rankings recognize hospitals that excel in treating patients with the most challenging conditions.
Announcement of new president for University Hospitals Seidman Cancer Center in Cleveland: Theodoros N. Teknos, MD.
Call for scholars to apply for research grants for innovative efforts seeking to prevent, treat, or cure blindness.
CLEVELAND – In the largest nursing home study to date on the effect of a high dose (HD) flu vaccine, researchers found that vaccines with four times the antigen of standard flu (SD) vaccines significantly reduced the risk of respiratory and all-cause hospitalization during flu season. The study found a 12.7 percent relative reduction in the incidence of hospitalization for respiratory illness, such as pneumonia, and an 8.5 percent reduction of all-cause hospitalizations among residents on Medicare who lived at nursing homes that received HD instead of SD flu vaccines. The findings are published in the journal The Lancet Respiratory Medicine.
University Hospitals Cleveland Medical Center and UH Harrington Heart & Vascular Institute announce the appointment of Mehdi H. Shishehbor, DO, PhD, MPH as Director of Cardiovascular Interventional Center. His areas of expertise include cardiology, vascular medicine, cardiovascular imaging, translational research and minimally invasive, catheter-based procedures such as angioplasty, stent grafts, stenting, atherectomy to treat coronary carotid artery disease, abdominal aortic aneurysms, and peripheral arterial and venous diseases.
The Level I trauma center at University Hospitals Cleveland Medical Center received verification from the American College of Surgeons, the organization that establishes criteria ensuring trauma care capability and institutional performance. UH's trauma center opened late in 2015 and has been operating under provisional status, as is customary until the ACS could conduct a review of the program. The final verification was issued in May.
Results from the DAWN stroke trial provide compelling evidence that selected patients suffering a major ischemic stroke recovered significantly better with mechanical retrieval of the blood clot with medical therapy compared with medical therapy alone when initiated past the current guidelines of within 6 hours and up to 24 hours of the stroke.
Announcement of nominations being sought for the Harrington Prize for Innovation in Medicine. Deadline for nominations is August 29, 2017. Nomination guidelines can be found at: HarringtonDiscovery.org/ThePrize
Andrew Sloan, MD, Director of the Brain Tumor and NeuroOncology Center at University Hospitals Cleveland Medical Center, presented new data supporting use of the NeuroBlate system for brain lesions at the 2017 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles on April 26.
It may be possible to predict the severity of hearing loss for children diagnosed with enlarged vestibular aqueduct, according to a new study published in JAMA-Otolaryngology-Head & Neck Surgery.
Story about the first patient enrolled in the new national phase I trial studying the side effects and best dose and schedule of pembrolizumab, an immunotherapy drug, when given together with chemotherapy and radiation therapy following surgery for very high risk head and neck cancer. Pembrolizumab is one of the first immunotherapy drugs.
Max Wiznitzer, MD, has a longstanding interest in neurodevelopmental disabilities, including autism.
A new investigational delivery method for localized vaginal estrogen therapy that utilizes an applicator free softgel to alleviate moderate-to-severe vaginal pain during intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), received high rates of patient satisfaction among post-menopausal women, according to post-trial survey results published in the journal Menopause. “These survey results show that something as simple as a change to a more elegant delivery system that is easier to use and not messy might empower more post-menopausal women to seek prescription treatment for VVA, and perhaps help them stay with the application guidelines for longer,” said study first author Sheryl Kingsberg, PhD, Division Chief, OB/GYN Behavioral Medicine, UH Cleveland Medical Center.
News release about the first person enrolled in the first stem cell trial for cystic fibrosis.
Two internationally recognized research leaders from UH Cleveland Medical Center and Case Western Reserve University School of Medicine have received Outstanding Investigator Awards from the NIH. The 7-year, $6.7 million dollar awards will advance molecular studies of colon cancer and age-related cardiovascular risks.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right